drugset / Trial / NCT02266524
Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate pharmacokinetics, safety, and tolerability of tamsulosin hydrochloride in children with voiding disorders
Timeline
- Start
- 2005-01
- Primary completion
- 2005-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tamsulosin | Other / unclassified | 0.1 mg | Oral |
| Subject | Tamsulosin | Other / unclassified | 0.2 mg | Oral |
| Subject | Tamsulosin | Other / unclassified | 0.4 mg | Oral |
| Subject | Tamsulosin | Other / unclassified | 0.8 mg | Oral |